Gene Expression Analysis Market by Offering, Application, End-user

Description

List of Tables

[188 Pages Report] The Gene Expression Analysis Market size was estimated at USD 4.00 billion in 2023 and expected to reach USD 4.30 billion in 2024, at a CAGR 7.80% to reach USD 6.77 billion by 2030.

Gene expression analysis refers to the process of studying the patterns and levels at which genes are transcribed and translated into proteins, underscoring the functional elements of genes in various biological contexts. This analysis encompasses quantifying the expression levels of genes across different conditions, tissues, or time points to elucidate their regulatory mechanisms, interactions, and roles in physiological or pathological states. The insights gained from gene expression analysis are pivotal for understanding the molecular foundations of diseases, identifying potential therapeutic targets, and developing personalized medicine approaches. The gene expression analysis market is undergoing rapid evolution propelled by technological advancements, such as high-throughput and next-generation sequencing, which have improved efficiency while reducing costs. This, alongside the increasing incidence of genetic disorders and cancer, raises the need for precise gene expression studies in both diagnostic and research realms, further buoyed by substantial investments from public and private entities in genomics research. However, the market faces substantial hurdles, including stringent regulatory frameworks that lengthen product development timelines and elevate costs, as well as the complexities associated with managing and interpreting vast amounts of data generated. Despite these challenges, future market opportunities lie in the rising interest in personalized medicine and the integration of artificial intelligence and machine learning to streamline data analysis.

KEY MARKET STATISTICS
Base Year [2023]	USD 4.00 billion
Estimated Year [2024]	USD 4.30 billion
Forecast Year [2030]	USD 6.77 billion
CAGR (%)	7.80%

Offering: Growing adoption of advanced instruments with specificity and scalability

Instruments for gene expression analysis include real-time PCR (qPCR) systems, next-generation sequencing (NGS) platforms, microarrays, and other specialized equipment used in measuring the expression levels of genes. Microarray scanners are instrumental in gene expression analysis, operating by fluorescently scanning DNA microarray slides. These devices enable high-throughput analysis, allowing researchers to simultaneously analyze the expression of a number of genes within multiple samples. NGS platforms are crucial to modern genomics research, providing an enhanced depth of data. Polymerase chain reaction (PCR) is a widely used technique that amplifies specific DNA sequences, making it a crucial tool for gene expression analysis, particularly in quantifying mRNA levels. Real-time PCR has become the new standard for detecting and quantifying nucleic acids owing to its precision, sensitivity, and speed.

Reagents and consumables encompass all the necessary inputs required to perform gene expression analysis, such as PCR reagents, buffers, primers, probes, and kits designed for specific platforms or applications. Assays and kits are pivotal in gene expression analysis for various genetic research and clinical diagnostic applications. These products are designed to simplify, expedite, and enhance the accuracy of gene expression studies. DNA microarray technology offers a powerful platform for the simultaneous analysis of the expression patterns of thousands of genes. This technology enables researchers to gain comprehensive insights into the underlying mechanisms of diseases, genetic variations, and cellular pathways. Enzymes are pivotal reagents in the gene expression analysis workflow, enabling various critical processes such as reverse transcription, DNA amplification, and cDNA synthesis. Different types of enzymes, such as reverse transcriptase, DNA polymerase, and ligases, find applications specific to the technique employed for gene expression analysis.

Services in gene expression analysis include consultancy, custom assay design, sample preparation, sequencing, data analysis, and interpretation. These are typically offered by specialized companies or academic core facilities to researchers lacking the necessary equipment or expertise.

Application: Rising significance of gene expression analysis in streamlining the identification of drug targets

Gene expression analysis has become integral to clinical diagnostics, enabling the identification of disease-specific biomarkers and facilitating personalized treatment plans. By analyzing the expression levels of genes in patient samples, medical professionals can diagnose diseases at a molecular level, predict disease progression, and monitor patient response to treatment. In drug discovery and development, gene expression analysis is employed to identify potential drug targets, understand the mechanisms of action of new drugs, and predict drug efficacy and toxicity. This leads to the development of more effective and safer drugs, significantly improving the drug development pipeline.

Regional Insights

The gene expression analysis market in the Americas, particularly in North America, has exhibited significant growth. This can be attributed to several factors, including advanced healthcare infrastructure, substantial investments in biotechnology and pharmaceutical research, and the presence of major market players. Initiatives by government bodies, such as the National Institutes of Health (NIH), alongside collaborations between academic institutions and biopharmaceutical companies, also contribute to the robust growth in this region. The rising prevalence of chronic and genetic diseases, combined with supportive government policies related to healthcare research, describes the high adoption of gene expression analysis technology in Europe. Investments in research infrastructure and a rising focus on healthcare improvement, particularly in the Gulf Cooperation Council (GCC) countries, are pivotal factors driving the market in the EMEA. Asia-Pacific is a rapidly growing market for gene expression analysis, with an increasing number of research activities in drug discovery and development, rising healthcare expenditures, and growing awareness about genetic diseases. Moreover, government initiatives aimed at bolstering biotechnology and pharmaceutical sectors and collaborations between academic institutions and industry are notably supporting the market growth in this region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Gene Expression Analysis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Gene Expression Analysis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Gene Expression Analysis Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioSpyder, Inc., CD Genomics, Charles River Laboratories International, Inc., Danaher Corporation, DiaSorin S.p.A., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Illumina Inc., Inotiv, Inc., LGC Limited, Merck KGaA, Meridian Bioscience, Inc., NanoString Technologies Inc., New England Biolab, Oxford Gene Technology IP Limited, Oxford Nanopore Technologies plc, Promega Corporation, QIAGEN N.V., Revvity, Inc., Standard BioTools, Takara Bio, Inc., Thermo Fisher Scientific Inc, and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Gene Expression Analysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

Offering
- Instruments
  - Microarray Scanners
  - Next-generation Sequencing (NGS) Platforms
  - PCR

Reagents & Consumables
- Assays & Kits
- DNA Microarray
- Enzymes

Services

Application
- Clinical Diagnostics
- Drug Discovery & Development

End-user
- Academic & Research Institutions
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Gene Expression Analysis Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Gene Expression Analysis Market?

3. What are the technology trends and regulatory frameworks in the Gene Expression Analysis Market?

4. What is the market share of the leading vendors in the Gene Expression Analysis Market?

5. Which modes and strategic moves are suitable for entering the Gene Expression Analysis Market?

Product Code: MRR-EA11B604F62B

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising prevalence of chronic diseases
  - 5.1.1.2. Increasing preference for gene-based diagnostics
  - 5.1.1.3. Growing advancements in gene editing technology, sequencing, and bioinformatics
- 5.1.2. Restraints
  - 5.1.2.1. Lack of skilled labor and expenses associated with the instruments and consumables
- 5.1.3. Opportunities
  - 5.1.3.1. Increasing focus on precision oncology
  - 5.1.3.2. Rising need for customized medicine
- 5.1.4. Challenges
  - 5.1.4.1. Concerns associated with the interpretation of data
5.2. Market Segmentation Analysis
- 5.2.1. Offering: Growing adoption of advanced instruments with specificity and scalability
- 5.2.2. Application: Rising significance of gene expression analysis in streamlining the identification of drug targets
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Gene Expression Analysis Market, by Offering

6.1. Introduction
6.2. Instruments
6.3. Reagents & Consumables
6.4. Services

7. Gene Expression Analysis Market, by Application

7.1. Introduction
7.2. Clinical Diagnostics
7.3. Drug Discovery & Development

8. Gene Expression Analysis Market, by End-user

8.1. Introduction
8.2. Academic & Research Institutions
8.3. Diagnostic Laboratories
8.4. Pharmaceutical & Biotechnology Companies

9. Americas Gene Expression Analysis Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Gene Expression Analysis Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Gene Expression Analysis Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
- 12.3.1. Thermo Fisher Scientific Launched the Invitrogen TaqMan Cells-to-CT Express Kit for Streamlined RNA Processing
- 12.3.2. Tempus launched Tempus xR, a standalone RNA Sequencing Test
- 12.3.3. QIAGEN Launched Enhanced QIAGEN CLC Genomics Workbench Premium
12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio